These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3202498)

  • 1. Pulmonary retention of iodobenzyl-propanediamine in humans. Effect of cigarette smoking.
    Pistolesi M; Miniati M; Petruzzelli S; Carrozzi L; Giani L; Bellina CR; Gerundini P; Fazio F; Giuntini C
    Am Rev Respir Dis; 1988 Dec; 138(6):1429-33. PubMed ID: 3202498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged lung retention of 131I-HIPDM in smokers.
    Liu CT; Wang DL; Oliaro A; Huang NQ; Tian JH
    Panminerva Med; 1994 Sep; 36(3):128-30. PubMed ID: 7877826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of [iodine-125]N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3- propanediamine lung uptake using an isolated-perfused lung model.
    Slosman DO; Brill AB; Polla BS; Alderson PO
    J Nucl Med; 1987 Feb; 28(2):203-8. PubMed ID: 3806224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria act as a reservoir for the basic amine HIPDM in the lung.
    Miniati M; Paci A; Cocci F; Ciarimboli G; Monti S; Pistolesi M
    Eur Respir J; 1996 Nov; 9(11):2306-12. PubMed ID: 8947076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of 131I-HIPDM in the patients with chronic obstructive pulmonary disease.
    Liu CT; Wang NQ; Oliaro A; Tian JH; Wang DL
    Panminerva Med; 1994 Sep; 36(3):124-7. PubMed ID: 7877825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-123-HIPDM lung imaging in pulmonary vein-banded pulmonary hypertension.
    Shih WJ; Cottrill CM; Coupal JJ; O'Connor W; Kung HF; Ryo UY
    J Nucl Med; 1990 May; 31(5):668-73. PubMed ID: 2341903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung tissue binding of iodobenzyl-propanediamine: involvement of beta-adrenergic receptors.
    Paci A; Ciarimboli G; Miniati M; Cocci F; Piras F; Pistolesi M
    J Pharm Biomed Anal; 1989; 7(12):1467-72. PubMed ID: 2562314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No-carrier-added radiosynthesis of [123I]HIPDM: N,N,N'-trimethyl-N'-(2-hydroxy-3-methyl-5-[123I] iodobenzyl)-1,3-propanediamine.
    Moerlein SM; Lannoye GS; Welch MJ
    Int J Rad Appl Instrum A; 1990; 41(3):253-7. PubMed ID: 2158950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation and metabolism of [125I]HIPDM in the rat pancreas.
    Saji H; Kuge Y; Tsutsumi D; Yamamoto K; Konishi J; Yokoyama A
    Ann Nucl Med; 1991 Nov; 5(4):157-61. PubMed ID: 1797071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioactive iodine exchange reaction of HIPDM: kinetics and mechanism.
    Lui B; Chang J; Sun JS; Billings J; Steves A; Ackerhalt R; Molnar M; Kung HF
    J Nucl Med; 1987 Mar; 28(3):360-5. PubMed ID: 3819852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new brain perfusion imaging agent: [I-123]HIPDM:N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3-propanediamine.
    Kung HF; Tramposch KM; Blau M
    J Nucl Med; 1983 Jan; 24(1):66-72. PubMed ID: 6401325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and kinetic considerations in the use of [125I]HIPDM for quantitative measurement of regional cerebral blood flow.
    Lucignani G; Nehlig A; Blasberg R; Patlak CS; Anderson L; Fieschi C; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1985 Mar; 5(1):86-96. PubMed ID: 3871785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tomographic assessment of regional cerebral perfusion using intravenous I-123 HIPDM and a rotating gamma camera.
    Fazio F; Lenzi GL; Gerundini P; Collice M; Gilardi MC; Colombo R; Taddei G; Del Maschio A; Paicentini M; Kung HF
    J Comput Assist Tomogr; 1984 Oct; 8(5):911-21. PubMed ID: 6332124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative dual-tracer studies of carbon-14 tryptophan and iodine-131 HIPDM in animal models of pancreatic diseases.
    Kubota K; Som P; Brill AB; Sacker DF; Meinken GE; Srivastava SC; Atkins HL
    J Nucl Med; 1989 Nov; 30(11):1848-55. PubMed ID: 2509648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of the metabolism and imaging of the lung in the patients with chronic obstructive pulmonary diseases using 131I-HIPDM].
    Liu CT
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Oct; 15(5):282-4, 319. PubMed ID: 1306411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single photon emission computed tomography (SPECT) brain imaging using N,N,N'-trimethyl-N'-(2 hydroxy-3-methyl-5-123I-iodobenzyl)-1,3-propanediamine 2 HCl (HIPDM): intractable complex partial seizures.
    Lee BI; Markand ON; Siddiqui AR; Park HM; Mock B; Wellman HH; Worth RM; Edwards MK
    Neurology; 1986 Nov; 36(11):1471-7. PubMed ID: 3489907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT perfusion imaging with 123I-HIPDM in a patient with pulmonary embolism.
    Petruzzelli S; Palla A; Prediletto R; Mazzuca N; Pistolesi M; Giuntini C
    J Nucl Med Allied Sci; 1989; 33(1):45-8. PubMed ID: 2787396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of I-123 HIPDM as a lung imaging agent.
    Shih WJ; Coupal JJ; Dillon ML; Kung HF
    Eur J Nucl Med; 1988; 14(1):21-4. PubMed ID: 3383904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary toxicity studies on N,N,N'-trimetyl-N' (2-hydroxyl-3-methyl-5-iodobenzyl)-1,3-propanediamine (HIPDM), a new brain perfusion imaging agent.
    Kostyniak PJ
    Drug Chem Toxicol; 1984; 7(5):451-62. PubMed ID: 6334599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of pulmonary mass defect by iodine-123 N,N,N'trimethyl-N'[2-hydroxy-3-methyl-5-iodobenzyl]-1,3-propanediamine lung imaging.
    Shih WJ; Coupal JJ; DeLand FH; Domstad PA; Brandenburg S; Dillon ML
    Clin Nucl Med; 1986 Sep; 11(9):632-3. PubMed ID: 3769356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.